ArticleHealth affairs (Project Hope)2012
HIV treatment produces economic returns through increased work and education, and warrants continued US support.
Article in Health affairs (Project Hope), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Evaluating predictive performance, validity, and applicability of machine learning models for predicting HIV treatment interruption: a systematic review.BMC global and public health · 2025Pooled it
- A hybrid simulation model of HIV program interventions: from transmission behavior to macroeconomic impacts.Therapeutic advances in drug safety · 2025Article
- Intergenerational spillover effects of antiretroviral therapy in sub-Saharan Africa: a scoping review and future directions for research.BMJ global health · 2023Article
- Article
- Article
- Research for health in the Americas.BMJ (Clinical research ed.) · 2018Article
- Task-shifting alcohol interventions for HIV+ persons in Kenya: a cost-benefit analysis.BMC health services research · 2017Article
- Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort Study.Open forum infectious diseases · 2016Article
- PEPFAR Funding Associated With An Increase In Employment Among Males in Ten Sub-Saharan African Countries.Health affairs (Project Hope) · 2015Article
- Antiretroviral therapy for the prevention of HIV transmission: what will it take?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2014Article
- Cost-effectiveness of HIV treatment as prevention in serodiscordant couples.The New England journal of medicine · 2013Article
- Financing HIV programming: how much should low- and middle-income countries and their donors pay?PloS one · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Federal expenditures are under scrutiny in the United States, and the merits of continuing and expanding the President's Emergency Plan for AIDS Relief (PEPFAR) to support access to antiretroviral therapy have become a topic of debate. A growing body of research on the economic benefits of treatment with antiretroviral therapy has important implications for these discussions. For example, research conducted since the inception of PEPFAR shows that HIV-infected adults who receive antiretroviral therapy often begin or resume productive work, and that children living in households with infected adults who are on treatment are more likely to attend school than those in households with untreated adults. These benefits should be considered when weighing the overall benefits of providing antiretroviral therapy against its costs, particularly in the context of discussions about the future of PEPFAR. A modest case can also be made in favor of having private companies in HIV-affected countries provide antiretroviral therapy to their employees and dependents, thus sharing some of the burden of funding HIV treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.